scholarly journals Peptide 946 Melanoma Vaccine

2020 ◽  
Author(s):  
Keyword(s):  
Melanoma Vaccine

Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial

1996 ◽  
Vol 3 (2) ◽  
pp. 110-117 ◽  
Author(s):  
Marc K. Wallack ◽  
Muthukumaran Sivanandham ◽  
Brian Whooley ◽  
Kristen Ditaranto ◽  
Alfred A. Bartolucci
Keyword(s):  
Vaccine Trial ◽  
Melanoma Vaccine ◽  
Clinical Responses

RNA Melanoma Vaccine: Induction of Antitumor Immunity by Human Glycoprotein 100 mRNA Immunization

1999 ◽  
Vol 10 (16) ◽  
pp. 2719-2724 ◽  
Author(s):  
W.-Z. Zhou ◽  
D.S.B. Hoon ◽  
S.K.S. Huang ◽  
S. Fujii ◽  
K. Hashimoto ◽  
...  
Keyword(s):  
Antitumor Immunity ◽  
Melanoma Vaccine ◽  
Glycoprotein 100

ITOC2 – 023. Integrated computational pipeline for development of personalised melanoma vaccine

2015 ◽  
Vol 51 ◽  
pp. S8-S9
Author(s):  
Jaitly Tanushree ◽  
Gupta Dr. Shailendra ◽  
Dorrie Dr. Jan ◽  
Gonzalez Pr. Julio Vera ◽  
Schaft Dr. Neils ◽  
...  
Keyword(s):  
Computational Pipeline ◽  
Melanoma Vaccine

Randomized, double-blind, clinical trial of a polyvalent melanoma vaccine in patients with stage III melanoma

1998 ◽  
Vol 16 ◽  
pp. S26 ◽  
Author(s):  
Jean-Claude Bystryn ◽  
Ruth Oratz ◽  
Richard Shapiro ◽  
Matthew Harris ◽  
Daniel Roses ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Stage Iii ◽  
Double Blind ◽  
Melanoma Vaccine ◽  
Double Blind Clinical Trial ◽  
Stage Iii Melanoma

Melanoma Vaccine ??? AVAX Technologies

BioDrugs ◽  
2003 ◽  
Vol 17 (1) ◽  
pp. 69-72 ◽  
Author(s):  
&NA;
Keyword(s):  
Melanoma Vaccine
Sign in / Sign up

Export Citation Format

Share Document